Real Estate
Filter News
Found 7,335 articles
-
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia
12/6/2023
GC Biopharma, a South Korean biopharmaceutical company, announced on December 6th that it has participated in the groundbreaking ceremony of a plasma fractionation plant held at Jababeka Industrial Estate in Indonesia, one of the company's overseas plant construction projects.
-
Sunshine Biopharma Moves Principal Office to New York City
12/4/2023
Sunshine Biopharma, Inc., a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals announced that it has moved its headquarters to New York City.
-
GC Biopharma establishes mRNA production facility in Hwasun, Korea
12/1/2023
GC Biopharma, a South Korean biopharmaceutical company, announced on November 30th that it has completed the construction mRNA production facility in its own vaccine production plant in Hwasun, Jeollanam-do, Korea, and will soon start the operation.
-
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
11/21/2023
SOHM, Inc., a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced its new manufacturing facility at Carlsbad.
-
Bio-Techne Achieves ISO 13485 Certification for Its Wallingford, CT Manufacturing Facility
10/16/2023
Bio-Techne Corporatio announced that its Wallingford, CT facility has received ISO 13485:2023 certification for its quality management system, demonstrating the company's commitment to producing products for clinical applications.
-
An increase in funding share and available lab space helps to keep the Bay State’s biotech and pharma sectors strong.
-
VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility
10/12/2023
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces that Dr. Jeffrey Lawson, currently the Company’s Chief Scientific Officer, will assume the role of CEO, succeeding Dr. Jan Öhrström who will continue as Chairman.
-
CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris
10/9/2023
CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th.
-
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
10/9/2023
Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
-
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
10/5/2023
Wheeler Bio, a contract development and manufacturing organization for next-gen protein therapeutics, announced the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices facility inside the Ziggurat building in Oklahoma City, OK.
-
Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients
9/26/2023
Recently has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai.
-
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
9/20/2023
PROCEPT BioRobotics® Corporation, a surgical robotics company focused on developing transformative solutions in urology, proudly announces the grand opening of its state-of-the-art global corporate headquarters in San Jose, California.
-
Santa Barbara Surgery Center is First in Southern California to Adopt New Wireless Technology for Arthroscopy
9/20/2023
De La Vina Surgicenter in Santa Barbara, CA, and medical device and technology company Lazurite® announced that De La Vina is the first healthcare center in Southern California to adopt Lazurite’s new ArthroFree® Wireless Surgical Camera System.
-
Astrea Bioseparations Expands Manufacturing and Warehousing Capacity to Support Growing Demand for Its Chromatography Solutions in North America
9/18/2023
Astrea Bioseparations announces the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography solutions in North American markets.
-
National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core
9/15/2023
Wexford Science & Technology, LLC announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases.
-
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee, Co. Kerry. Ireland
9/14/2023
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry.
-
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
9/7/2023
Codexis, Inc., a leading enzyme engineering company, announced the Company has executed an Assignment and Assumption of Lease for its San Carlos, California location.
-
HealthTrackRx Expands National Footprint with Los Angeles Area PCR Laboratory
8/22/2023
HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, announced the opening of its latest high-throughput lab in Los Angeles, CA.
-
ChemDiv Establishes a Cutting-edge Biology Facility in Portugal
8/16/2023
ChemDiv Inc, a global leader in drug discovery and drug development solutions, shares the progress in the development of its cutting-edge biology facility at Biocant Park, Cantanhede, Portugal.
-
Breaking New Ground: Merck KGaA, Darmstadt, Germany’s Major Life Science Solar Energy Initiative Powers Up at Darmstadt Site
7/24/2023
By 2030, Merck KGaA, Darmstadt, Germany's sustainability strategy aims for a 50% reduction in Scope 1 and Scope 2 emissions as compared to 2020.